These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4154767)

  • 1. [Clinical investigation of o-(2-hydroxy-3-(tert.-butylamino)-propoxy)-benzonitrile under glucose load by means of continuous recording].
    Regula H; Papner B
    Arzneimittelforschung; 1974 Sep; 24(9):1328-30. PubMed ID: 4154767
    [No Abstract]   [Full Text] [Related]  

  • 2. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 3. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].
    Klemm W; Wenzel A
    Pharmazie; 1975 Oct; 30(10):675-7. PubMed ID: 695
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings].
    Bianchetti G; Gomeni R; Kilborn JR; Morselli PL; Taylor EA; Warrington SJ
    Br J Clin Pharmacol; 1979 Oct; 8(4):403P-404P. PubMed ID: 41556
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atypical dose-frequency relation as characteristic of a beta receptor blocker].
    Klempt HW; Müller WD; Bender F
    Verh Dtsch Ges Inn Med; 1973; 79():1015-8. PubMed ID: 4151337
    [No Abstract]   [Full Text] [Related]  

  • 6. [Simultaneous application of a beta-adrenergic sympathicomimetic and beta-adrenergic antagonist during inhibition of labor (author's transl)].
    Müller-Tyl E; Reinold E; Hernuss P
    Z Geburtshilfe Perinatol; 1974 Apr; 178(2):128-34. PubMed ID: 4154069
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Preliminary studies of Ro 3-3528, a beta-adrenoceptor-blocking agent, in man.
    Hicks DC; Phillips EM
    Br J Pharmacol; 1972 Feb; 44(2):377P-378P. PubMed ID: 4148922
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of beta receptor blockaders on pulse wave velocity. Studies of the new beta bockader Kö 1366].
    Klein K
    Wien Klin Wochenschr; 1973 Aug; 85(31):536-9. PubMed ID: 4147490
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetics of two beta blocking drugs: detection of a pharmacogenetic abnormality].
    Balant L; Gorgia A; Tschopp JM; Revillard C; Fabre J
    Schweiz Med Wochenschr; 1976 Oct; 106(41):1403-7. PubMed ID: 12563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of the route of administration on the metabolism of a beta-adrenergic blocker, o-[3-(tert-butylamino)-2-hydroxypropoxy]-benzonitrile (bunitrolol) (author's transl)].
    Rikihisa T; Toyama S; Mori M; Suzuki T
    Yakugaku Zasshi; 1978 Sep; 98(9):1258-66. PubMed ID: 32380
    [No Abstract]   [Full Text] [Related]  

  • 12. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115). 1. Blood levels in dogs].
    Femmer K; Klemm W; Nürnberger H
    Pharmazie; 1975 Oct; 30(10):673-5. PubMed ID: 694
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
    Noguchi Y; Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
    [No Abstract]   [Full Text] [Related]  

  • 14. [Smoking and beta adrenergic receptor blockade].
    Carlsen JE; Svendsen TL; Christensen NJ; Trap-Jensen J
    Ugeskr Laeger; 1980 Feb; 142(8):504-8. PubMed ID: 6102813
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of a short-term oral administration of trimepranol on plasma renin activity (author's transl)].
    Slabý A; Dosková M; Horký K; Urbánek J; Reiseauer R
    Sb Lek; 1975 Apr; 77(4):102-6. PubMed ID: 238277
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nadolol in the preventive treatment of migraine].
    Szczudlik A
    Wiad Lek; 1984 Jul; 37(14):1087-92. PubMed ID: 6151319
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proceedings: Clinical experiences with a new beta adrenergic blocking agent KO 1366 (0-[2-hydroxy-3-(tertiarybutylamino)-propoxy]-benzonitrile-hydrochloride)].
    Fujise S; Takada T; Osanai S; Abe H
    Jpn Circ J; 1975 Jun; 39(6):736-7. PubMed ID: 239261
    [No Abstract]   [Full Text] [Related]  

  • 18. [Circulatory changes caused by a beta blocker. 1. Y-6124(Adobiol)].
    Shimamura K; Yoshida Y; Sakio H; Yasui A; Nakagawa K
    Masui; 1974 Oct; 23(11):1110-6. PubMed ID: 4155449
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-sympatholytics as non-specific inhibitors of serum cholin-esterase.
    Hellenbrecht D; Müller KF
    Experientia; 1973 Oct; 29(10):1255-7. PubMed ID: 4148482
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: The hypoglycaemic action of ICI 66082 (4-(2-hydroxy-3-isopropyl-aminopropoxy) phenyl acetamide) in the rat.
    Furman BL; Tayo FM
    Br J Pharmacol; 1974 Sep; 52(1):143P. PubMed ID: 4155984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.